PCRX
Pacira Biosciences
$36.38
−$0.04 (−0.11%)Oct 26, 2026
Key metrics
The numbers that frame PCRX today
- Market cap
- $1.45B
- P/E (TTM)
- 103.9
- EV / FCF
- 9.2
- Gross margin
- 79.2%
- EV / Sales
- 2.2
- ROIC
- 3.2%
- Div yield
- 0%
- Debt / equity
- 0.6
- 52wk Low
- $18.80
- 52wk High
- $36.67
Growth
Revenue and earnings trend for PCRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PCRX
Is Pacira Biosciences a good buy?
Yes. Pacira Biosciences has excellent quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Pacira Biosciences is selling at a low price.
What is the market capitalization of PCRX?
Pacira Biosciences's market capitalization is $1.45B.
What is the P/E (TTM) ratio for PCRX stock?
Pacira Biosciences's P/E (TTM) ratio is 103.9, based on trailing earnings.
What is the 52-week high for PCRX stock?
The 52-week high for Pacira Biosciences is $36.67. The current close of $36.38 is 0.8% below that high.
What is the 52-week low for PCRX stock?
The 52-week low for Pacira Biosciences is $18.80. The current close of $36.38 is 93.5% above that low.
Does PCRX stock pay dividends?
Pacira Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PCRX?
Pacira Biosciences's Debt / Equity ratio is 0.61.